组织工程与重建外科杂志

组织工程与重建外科杂志 ›› 2015, Vol. 11 ›› Issue (5): 313-315.doi: 10.3969/j.issn.1673-0364.2015.05.007

• 论著 • 上一篇    下一篇

胸大肌肌瓣转移术预防乳腺癌术后上肢淋巴水肿的临床研究

王颖，陈飞，孙鹤庆，路选   

  1. 扬州市第一人民医院乳腺外科
  • 发布日期:2020-07-23

Clinical Research of the Pectoralis Major Myocutaneous Flap Transfer in the Prevention of Breast Cancer-related Lymphedema after Modified Radical Mastectomy

WANG Ying, CHEN Fei, SUN Heqing, LU Xuan   

  1. Department of Breast Surgery, Yangzhou First People ＇s Hospital, Yang＇zhou 225001, China）
  • Published:2020-07-23

摘要： 目的 探讨胸大肌肌瓣转移术对乳腺癌改良根治术后患侧上肢淋巴水肿的预防效果。方法 自2013年9月至2014年6月,将68例乳腺癌患者分成2组,35例行乳腺癌改良根治术+胸大肌肌瓣转移术(干预组),33例单纯行乳腺癌改良根治术(对照组),术后随访观察,分别在术后2周、1个月、3个月、6个月和9个月测量双侧臂围,判断有无上肢淋巴水肿的发生及程度。结果 随访结果表明,干预组和对照组相比,术后患侧上肢淋巴水肿发生率明显减少,差异具有统计学意义(P<0.05)。结论 乳腺癌改良根治术后行胸大肌肌瓣转移术,可显著减少乳腺癌术后患侧上肢淋巴水肿的发生率,提高患者的生活质量。

关键词: 乳腺癌, 胸大肌肌瓣转移术, 上肢淋巴水肿

Abstract: Objective To investigate the clinical effect of Pectoralis major myocutaneous flap transfer on the prevention of breast cancer-related lymphedema after modified radical mastectomy. Methods From September 2013 to June 2014, 68 patients with breast cancer were included and divided into 2 groups, interventional group and control group. The patients in interventional group were treated with modified radical mastectomy plus Pectoralis major myocutaneous flap transfer, while the patients in control group were just received mastectomy. All the patients were followed and the upper extremity lymphedema was evaluated 0.5, 1, 3, 6, 9 months after surgery. Results According to the follow-up results, the incidence of lymphedema in interventional group was obviously lower than in control group, the difference was significant （P〈0.05）. Conclusion The Pectoralis major myocutaneous flap transfer after modified radical mastectomy can significantly reduce the chances of upper limb lymphedema, and accelerate the postoperative recovery.

Key words: Breast cancer, Pectoralis major muscleflap transfer, Upper limb lymphedema

中图分类号: